- Home
- MTEN vs ACXP Comparison
MTEN vs ACXP Comparison
Compare MTEN & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEN
- ACXP
- Stock Information
- Founded
- MTEN 2015
- ACXP 2017
- Country
- MTEN China
- ACXP United States
- Employees
- MTEN N/A
- ACXP N/A
- Industry
- MTEN Building Products
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- MTEN Industrials
- ACXP Health Care
- Exchange
- MTEN Nasdaq
- ACXP Nasdaq
- Market Cap
- MTEN 82.6M
- ACXP 6.8M
- IPO Year
- MTEN 2024
- ACXP 2021
- Fundamental
- Price
- MTEN $11.75
- ACXP $4.12
- Analyst Decision
- MTEN
- ACXP Strong Buy
- Analyst Count
- MTEN 0
- ACXP 3
- Target Price
- MTEN N/A
- ACXP $143.67
- AVG Volume (30 Days)
- MTEN 60.9K
- ACXP 67.3K
- Earning Date
- MTEN 10-18-2025
- ACXP 11-12-2025
- Dividend Yield
- MTEN N/A
- ACXP N/A
- EPS Growth
- MTEN N/A
- ACXP N/A
- EPS
- MTEN N/A
- ACXP N/A
- Revenue
- MTEN $10,120,257.00
- ACXP N/A
- Revenue This Year
- MTEN N/A
- ACXP N/A
- Revenue Next Year
- MTEN N/A
- ACXP N/A
- P/E Ratio
- MTEN N/A
- ACXP N/A
- Revenue Growth
- MTEN 23.03
- ACXP N/A
- 52 Week Low
- MTEN $3.20
- ACXP $3.80
- 52 Week High
- MTEN $26.03
- ACXP $44.00
- Technical
- Relative Strength Index (RSI)
- MTEN 43.04
- ACXP 36.61
- Support Level
- MTEN $10.27
- ACXP $4.09
- Resistance Level
- MTEN $12.75
- ACXP $4.34
- Average True Range (ATR)
- MTEN 0.84
- ACXP 0.45
- MACD
- MTEN 0.09
- ACXP 0.10
- Stochastic Oscillator
- MTEN 56.92
- ACXP 8.73
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.